CoChat

Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures

Open access
Vander Velde, Robert, Yoon, Nara, Marusyk, Viktoriya, Durmaz, Arda, Dhawan, Andrew, Miroshnychenko, Daria, Lozano-Peral, Diego, Desai, Bina, Balynska, Olena, Poleszhuk, Jan, Kenian, Liu, Teng, Mingxiang, Abazeed, Mohamed, Mian, Omar, Tan, Aik Choon, Haura, Eric, Scott, Jacob, Marusyk, Andriy · 2020 · Nature Communications
Cited by 138

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Despite high initial efficacy, targeted therapies eventually fail in advanced cancers, as tumors develop resistance and relapse. In contrast to the substantial body of research on the molecular mechanisms of resistance, understanding of how resistance evolves remains limited. Using an experimental model of ALK positive NSCLC, we explored the evolution of resistance to different clinical ALK inhibitors. We found that resistance can originate from heterogeneous, weakly resistant subpopulations with variable sensitivity to different ALK inhibitors. Instead of the commonly assumed stochastic single hit (epi) mutational transition, or drug-induced reprogramming, we found evidence for a hybrid scenario involving the gradual, multifactorial adaptation to the inhibitors through acquisition of multiple cooperating genetic and epigenetic adaptive changes. Additionally, we found that during this adaptation tumor cells might present unique, temporally restricted collateral sensitivities, absent in therapy naïve or fully resistant cells, suggesting the potential for new therapeutic interventions, directed against evolving resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-16212-w

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 138

Metadata

Authors
Vander Velde, R., Yoon, N., Marusyk, V., Durmaz, A., Dhawan, A., Miroshnychenko, D., Lozano-Peral, D., Desai, B., Balynska, O., Poleszhuk, J., Kenian, L., Teng, M., Abazeed, M., Mian, O., Tan, A. C., Haura, E., Scott, J., & Marusyk, A.
Venue
Nature Communications
Published
2020-05-14
Volume
11
Issue
1
Pages
2393-2393
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3025648972
Cited by
138
References
19
FWCI
7.51
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures. https://app.cochat.ai/papers/10.1038/s41467-020-16212-w
The paper
Vander Velde, R., Yoon, N., Marusyk, V., Durmaz, A., Dhawan, A., Miroshnychenko, D., Lozano-Peral, D., Desai, B., Balynska, O., Poleszhuk, J., Kenian, L., Teng, M., Abazeed, M., Mian, O., Tan, A. C., Haura, E., Scott, J., & Marusyk, A. (2020). Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures. Nature Communications. https://doi.org/10.1038/s41467-020-16212-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.